-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier: Ernexa Therapeutics Amends Certificate Of Incorporation To Increase Authorized Common Stock From 100M To 150M Shares

Benzinga·06/03/2025 14:50:51
Listen to the news

Effective June 2, 2025, Ernexa Therapeutics Inc. (the "Company"), filed a certificate of amendment to the Company's Restated Certificate of Incorporation, as amended (the "Amended COI") with the Secretary of State of Delaware to increase the authorized shares of its common stock from 100,000,000 to 150,000,000.

 

Additionally, effectively June 2, 2025, the Company filed a certificate of amendment to its Amended COI with the Secretary of State of Delaware to allow for action required or permitted to be taken by stockholders of the Company to be effected by written consent of such stockholders in addition to duly called annual or special meetings of such stockholders.